Rallybio Corporation (RLYB) Misses Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices steady as investors weigh US-Iran war escalation
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Pentagon reportedly locked down, hazmat teams responding
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Rallybio Corp. (RLYB) PT Lowered to $20 at Jones Trading
March 13, 2024 4:11 PM EDTJones Trading analyst Catherine Novack lowered the price target on Rallybio Corp. (NASDAQ: RLYB) to $20.00 (from $30.00) while maintaining a Buy rating.
The analyst comments "Rallybio reported 4Q23 earnings ( press release ). Earlier this year, the company announced portfolio prioritization to extend runway... More
